US2916416A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Aspirin-modified coconut oil liquid suspensions
Assignee: Bristol Laboratories Inc
•
Filing: 1955-06-30
•
Granted: 1959-12-08
•
Expires: 1975-06-30
Abstract
No abstract record available.
Inventors
- 👤 Buckwalter Frank Harold
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 20:58
CPC Classifications
A; A61; A61K; A61K47/00; A61K47/44
Claims Analysis
Total Claims: 2
Claim 1
Independent Claim
74 words
A HIGHLY PALATABLE AND ACCEPTABLE, STABLE LIQUID SUSPENSION FOR ORAL THERAPEUTIC USE COMPRISING ASPIRIN AND MODIFIED COCONUT OIL HAVING A SETTING POINT BELOW 60*F., SAID SUSPENSION UPON ORAL ADMINISTRATION TO MAN IN AN AMOUNT PROVIDING A DOSE OF FIVE GRAINS OF ASPIRIN GIVING HIGHER AVERAGE BLOOD LEVELS OF SALICYCLIC ACID THAN THOSE OBTAINED BY ORAL ADMINISTRATION OF TEN GRAINS OF ASPIRIN IN TABLET FORM IN THE PERIOD FROM TEN TO TWENTY MINUTES AFTER ADMINISTRATION.
Claim 2
Dependent Claim
74 words
A HIGHLY PALATABLE AND ACCEPTABLE, STABLE LIQUID SUSPENSION FOR ORAL THERAPEUTIC USE COMPRISING ASPIRIN AND MODIFIED COCONUT OIL HAVING A SETTING POINT BELOW 60*F., SAID SUSPENSION UPON ORAL ADMINISTRATION TO MAN IN AN AMOUNT PROVIDING A DOSE OF FIVE GRAINS OF ASPIRIN GIVING HIGHER AVERAGE BLOOD LEVELS OF SALICYCLIC ACID THAN THOSE OBTAINED BY ORAL ADMINISTRATION OF TEN GRAINS OF ASPIRIN IN TABLET FORM IN THE PERIOD FROM TEN TO TWENTY MINUTES AFTER ADMINISTRATION.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1962-12-07 | 1963-06-08 | 1963-12-08 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1966-12-07 | 1967-06-08 | 1967-12-08 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1970-12-07 | 1971-06-08 | 1971-12-08 | $7700.00 | Window Closed / Lapsed |